SSKN
STRATA Skin Sciences Inc
NASDAQ: SSKN · HEALTHCARE · MEDICAL DEVICES
$0.14
+3.92% today
Updated 2026-04-29
Market cap
$824350.00
P/E ratio
—
P/S ratio
0.03x
EPS (TTM)
$-1.35
Dividend yield
—
52W range
$0 – $4
Volume
0.1M
STRATA Skin Sciences Inc (SSKN) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-20.40%
Operating margin
0.40%
ROE
-158.90%
ROA
-11.10%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | — | $-10.59M | — | — | — |
| 2007 | — | $-11.94M | — | — | — |
| 2008 | $10000.00 | $-17.61M | — | -182,741.97% | -176,050.31% |
| 2009 | — | $-18.45M | — | — | — |
| 2010 | — | $-19.92M | — | — | — |
| 2011 | $0.00 | $-20.38M | — | — | — |
| 2012 | $278461.00 | $-22.67M | -633.44% | -8,160.77% | -8,142.25% |
| 2013 | $536000.00 | $-25.95M | -709.89% | -4,502.61% | -4,841.04% |
| 2014 | $915000.00 | $-16.03M | -439.34% | -1,816.61% | -1,752.13% |
| 2015 | $18.50M | $-27.91M | 25.82% | -89.08% | -150.90% |
| 2016 | $31.76M | $-3.33M | 60.21% | -11.33% | -10.50% |
| 2017 | $31.45M | $-21.51M | 57.08% | -7.66% | -68.41% |
| 2018 | $29.86M | $-4.03M | 57.34% | -11.24% | -13.51% |
| 2019 | $31.59M | $-3.79M | 64.17% | -9.53% | -12.00% |
| 2020 | $23.09M | $-4.41M | 61.21% | -17.65% | -19.11% |
| 2021 | $29.98M | $-2.71M | 66.22% | -14.68% | -9.03% |
| 2022 | $36.16M | $-5.55M | 60.20% | -12.86% | -15.35% |
| 2023 | $33.36M | $-10.83M | 55.34% | -25.79% | -32.47% |
| 2024 | $33.56M | $-10.09M | 56.85% | -27.58% | -30.05% |
| 2025 | $30.70M | $-6.26M | 58.25% | -19.01% | -20.40% |